Qube Research & Technologies (QRT) Portfolio holdings
AUM $72B
1-Year Return
7.86%
This Quarter Return
+5.21%
1 Year Return
+7.86%
3 Year Return
+23.62%
5 Year Return
+38.38%
10 Year Return
–
AUM
$54.6B
AUM Growth
+$447M
(+0.83%)
Cap. Flow
-$2.64B
Cap. Flow
% of AUM
-4.83%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
3,869
New
513
Increased
1,122
Reduced
961
Closed
1,124
Top Buys
| 1 |
NVIDIA
NVDA
|
+$836M |
| 2 |
Bank of America
BAC
|
+$498M |
| 3 |
Microsoft
MSFT
|
+$314M |
| 4 |
Spotify
SPOT
|
+$245M |
| 5 |
Intuit
INTU
|
+$244M |
Top Sells
| 1 |
Apple
AAPL
|
+$852M |
| 2 |
Broadcom
AVGO
|
+$688M |
| 3 |
Amazon
AMZN
|
+$646M |
| 4 |
Accenture
ACN
|
+$482M |
| 5 |
Visa
V
|
+$406M |
Sector Composition
| 1 | Technology | 19.73% |
| 2 | Industrials | 13.15% |
| 3 | Healthcare | 12.31% |
| 4 | Financials | 12.25% |
| 5 | Consumer Discretionary | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Amylyx Pharmaceuticals
AMLX
$1.36B
| $596K | ﹤0.01% |
183,894
-605,233
| -77% | -$1.96M |
|
1827
Viavi Solutions
VIAV
$2.72B
| $594K | ﹤0.01% |
65,855
-617,284
| -90% | -$5.57M |
|
1828
Vera Therapeutics
VERA
$1.57B
| $591K | ﹤0.01% |
+13,376
| New | +$591K |
|
1829
Fidelity Blue Chip Growth ETF
FBCG
$4.85B
| $590K | ﹤0.01% |
13,803
+9,057
| +191% | +$387K |
|
1830
First Trust Dorsey Wright Focus 5 ETF
FV
$3.71B
| $586K | ﹤0.01% |
10,062
-2,461
| -20% | -$143K |
|
1831
nLIGHT
LASR
$1.47B
| $584K | ﹤0.01% |
54,649
+31,441
| +135% | +$336K |
|
1832
Southern Missouri Bancorp
SMBC
$623M
| $583K | ﹤0.01% |
10,318
+1,409
| +16% | +$79.6K |
|
1833
Arcturus Therapeutics
ARCT
$490M
| $582K | ﹤0.01% |
25,090
+18,488
| +280% | +$429K |
|
1834
C&F Financial
CFFI
$224M
| $582K | ﹤0.01% |
9,969
+4,116
| +70% | +$240K |
|
1835
iShares Preferred and Income Securities ETF
PFF
$14.8B
| $582K | ﹤0.01% |
17,502
+8,353
| +91% | +$278K |
|
1836
Aramark
ARMK
$9.85B
| $580K | ﹤0.01% |
+14,988
| New | +$580K |
|
1837
Southside Bancshares
SBSI
$902M
| $578K | ﹤0.01% |
17,284
-2,083
| -11% | -$69.6K |
|
1838
ARS Pharmaceuticals
SPRY
$946M
| $576K | ﹤0.01% |
+39,696
| New | +$576K |
|
1839
Seanergy Maritime Holdings
SHIP
$186M
| $573K | ﹤0.01% |
46,150
+462
| +1% | +$5.74K |
|
1840
Sally Beauty Holdings
SBH
$1.51B
| $572K | ﹤0.01% |
+42,173
| New | +$572K |
|
1841
IBEX
IBEX
$540M
| $569K | ﹤0.01% |
+28,480
| New | +$569K |
|
1842
Primis Financial Corp
FRST
$264M
| $567K | ﹤0.01% |
46,589
+12,266
| +36% | +$149K |
|
1843
Artivion
AORT
$1.88B
| $566K | ﹤0.01% |
+21,262
| New | +$566K |
|
|
OPRA
1844
Opera Ltd
OPRA
$1.74B
| $566K | ﹤0.01% |
36,602
+11,960
| +49% | +$185K |
|
1845
Gladstone Capital
GLAD
$520M
| $564K | ﹤0.01% |
23,444
-14,306
| -38% | -$344K |
|
1846
Vanguard Small-Cap Value ETF
VBR
$31.5B
| $563K | ﹤0.01% |
2,805
+363
| +15% | +$72.9K |
|
|
BOW
1847
Bowhead Specialty Holdings
BOW
$979M
| $562K | ﹤0.01% |
20,054
+18,854
| +1,571% | +$528K |
|
1848
Lindsay Corp
LNN
$1.52B
| $559K | ﹤0.01% |
4,482
+3,411
| +318% | +$425K |
|
1849
Wave Life Sciences
WVE
$1.08B
| $558K | ﹤0.01% |
+68,041
| New | +$558K |
|
|
ALX
1850
Alexander's
ALX
$1.19B
| $557K | ﹤0.01% |
2,300
+920
| +67% | +$223K |
|